Global Bacteriophages Therapy Market is Growing With a CAGR Of 5.7% in the Forecast Period of 2021 to 2028

The Global Bacteriophages Therapy Market is growing due to factors such as the rising incidence of antibiotic-resistant infections and increasing research and development activities. Moreover, the increased government funding and technological advancements have propelled the demand of the bacteriophages therapy market. However, the high cost associated with the therapy may hamper the market growth.

Global Bacteriophages Therapy Market Scenario                      

According to Data Bridge Market Research, the market for bacteriophages therapy is growing globally with market leaders such as Microgen, which accounts for an estimated market share of approximately 24.97%, followed by Adaptive Phage Therapeutics estimated market share of 10.15%, and Phagelux, Inc. estimated market share of 10.14%. The companies have gained outstanding sales by providing bacteriophages therapy.   

  • In October 2018, Microgen announced that Russian Bacteriophages are used in the prevention of emergency infections. The company further added that over 3,000 products had been delivered to the Kuban. This has helped the company to earn more revenue
  • In July 2017, Microgen announced that bacteriophages ensured infection control in the Tyumen oblast. The product is effective in controlling intestinal infections, even for pregnant and lactating women and newborns. This has helped the company to continue development and increase profit margins

Bacteriophages Therapy Market Trends Impacting the Market

Now the question is which other regions Microgen, Adaptive Phage Therapeutics, Phagelux, Inc. are targeting? Data Bridge Market Research has forecasted a large growth in the Asia Pacific global bacteriophages therapy market and the market leaders targeting Japan and China to be their next pocket revenue for 2021.

The global bacteriophages therapy market is becoming more competitive every year with companies like Adaptive Phage Therapeutics, Phagelux, Inc, LOCUS BIOSCIENCES, INC., among others which are the market leaders for bacteriophages therapy.

 The data bridge market research new reports highlight the significant growth factors and opportunities in the global bacteriophages therapy market.        

For more analysis on the global bacteriophages therapy market, request a briefing with our analysts

Latest Market Developments in 2021

  • In June, Adaptive Phage Therapeutics announced the initiation of phase 1/2 study of bacteriophage therapy (Phage Bank) to evaluate the safety, tolerability, and efficacy of targeted, personalized bacteriophage ("phage") treatments in patients with urinary tract infection (UTI). This has helped the company to develop a novel treatment for multi-drug-resistant bacterial infections.
  • In April, Phagelux, Inc. announced that the company has entered into multiple commercial collaborations such as European sales, marketing, and product development collaboration with DCM for its AgriPhage line of biopesticides, among others. This has helped the company to explore and develop next-generation bacteriophages fully

Scope of global bacteriophages therapy  

The global bacteriophages therapy market is segmented on the basis of countries into the U.S., Canada, Georgia, Russia, Belgium, Poland, France, Netherlands, UK, Italy, Germany, Turkey, Switzerland, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, rest of Asia-Pacific, South Africa, Saudi Arabia, Egypt, Israel and rest of the Middle East and Africa, Brazil, Argentina and rest of South America

  • All country-based analysis of the global bacteriophages therapy market is further analyzed based on maximum granularity into further segmentation. On the basis of target, the bacteriophages therapy market is segmented into Escherichia coli, staphylococcus, streptococcus, pseudomonas, salmonella, and others. On the basis of type, the bacteriophages therapy market is segmented into lytic and lysogenic. On the basis of the base, the bacteriophages therapy market is segmented into sterile broth culture and water-soluble jelly base. On the basis of application, the bacteriophages therapy market is segmented into bacterial dysentery, infection of the skin and nasal mucosa, suppurative skin infections, lung, and pleural infections, post-operative wound infections, others. On the basis of route of administration, the bacteriophages therapy market is segmented into oral, parenteral, dermal, rectal, others. On the basis of end-users, the bacteriophages therapy market is segmented into hospitals, specialty clinics, academic research, and institutes, among others. On the basis of distribution channels, the bacteriophages therapy market is segmented into direct tender, third-party distributors.

To know more about the study

Key Pointers Covered in Global Bacteriophages therapy Market Trends and Forecast to 2028

  • Market size
  • Top to bottom market analysis
  • Recent developments for market competitors
  • Recent market value for different countries
  • Market value and overview of bacteriophages therapy market
  • Company profiling of top eight players of bacteriophages therapy market

Key Market Competitors Covered in the Report

  • Intralytix, Inc. 
  • Adaptive Phage Therapeutics
  • Armata pharmaceuticals, Inc.
  • Delmont Laboratories, Inc.
  • Pherecydes Pharma
  • Pylum
  • iNtODEWORLD, Inc.   
  •  EnBiotix, Inc.
  •  Fixed-Phage Limited
  • Microgen
  •  Phagelux, Inc.
  • ATCC
  • Cytophage Technologies Inc.
  • Arthur Andrew Medical

Above are the key players covered in the report. To know about more and exhaustive list of bacteriophages therapy, contact us

Research Methodology: Global Analytical Laboratory Services Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or can drop down your inquiry.

The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market timeline analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis, and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Healthcare Professionals, Research Laboratories,
  • Supply Side: Manufactures, Service Providers, CRO's

Related Reports

Browse in Healthcare Category Related Reports@